Drug Database · Clinicians

Chlorphenamine + Guaifenesin + Phenylpropanolamine

Also known as: chlorpheniramine (US name, for chlorphenamine) · guaiphenesin (former British name, for guaifenesin)

Brands (19) Conzend, Deconsaph, Deconsaph-Plus…Show all

Expectorant/ nasal decongestant/ antihistamine; Antihistamine/Nasal Decongestant/Expectorant; and others PH FDA category
Fixed-dose combination.

Controlled precursorRx · Prescription drugOTC · Over-the-counter19 PH products

1988 Convention Table I (norephedrine); FDA-registered oral preparations are exempt from all DDB regulatory requirements except registration and licensing of the importer, exporter and manufacturer; prescription and dispensing follow FDA rules (BR 1 s.2014 Sec. 4(5)). Parenteral preparations are not covered by this exemption (Sec. 4(2)(c)(i)); prescribing a drug preparation containing a controlled chemical otherwise requires a PDEA S-2 license (Sec. 6(3)).; BR 1 s.2014 Sec. 6(14)-(15): preparations with norephedrine/phenylpropanolamine 25 mg or below that are classified over-the-counter may be advertised to the public and distributed as samples; the S-2 license fee schedule (Sec. 6) likewise excludes them. The precursor exemption for oral FDA-registered preparations applies to combinations as well (BR 1 s.2014 Sec. 4(5)). Source: DDB, Updated Lists of Scheduled Controlled Substances (as of 20 July 2026); DDB Board Regulation No. 1, s. 2014 (amending BR 3 s. 2003: licensing, prescriptions, exemptions).

Dispensing: Over-the-counter (OTC) · Prescription (Rx) · Controlled precursor Last updated: Audience: Licensed health professionals
US label not yet available for this generic. Check the Philippine package insert (linked in the products table where the FDA has published one).

Component information

No US or EU label exists for this exact combination, so information is shown for each component.

  • Use: Uses temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat US FDA label

  • Use: Uses helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive US FDA label

Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney dosing for each component (single-agent) is shown under Component information.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Syrup: 2 mg/5 mg/100 mg per 5 mL, 50 mg/6.25 mg/1 mg per 5 mL, 100 mg 6.5 mg/2 mg per 45 mL, 100 mg/15 mg/2 mg per 5 mL, 100 mg/2 mg/6.5 mg per 5 mL, 100 mg/5 mg/2 mg per 5 mL, 100 mg/6.5 mg/2 mg, 100 mg/6.5 mg/2 mg per 5 mL

Registered products in the Philippines

19 products registered with the Food and Drug Administration (FDA) Philippines list Chlorphenamine + Guaifenesin + Phenylpropanolamine as the generic name (including products registered under a variant spelling). Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Also registered under: Guaifenesin + Phenylpropanolamine HCl + Chlorphenamine Malaeate (1 product) · Guaifenesin + Chlorpheniramine Maleate + Phenylpropanolamine Hydrochloride (1 product) · Guiafenesin + Chlorpheniramine Maleate + Phenylpropanolamine Hydrochloride (1 product) · Guaifenesin + Phenylpropanolamine HC1 Chlorphenamine Maleate (1 product). Products registered under these spellings are included in the table and marked.

Verify on PH FDA portal

All registered products19
Philippine FDA-registered products for Chlorphenamine + Guaifenesin + Phenylpropanolamine
Package insert
ConzendGuaifenesin + Phenylpropanolamine hydrochloride + Chlorphenamine maleate
50 mg/ 6.25 mg/ 1 mg per 5 mL SyrupAmber Bottle x 60 mL and 120 mL (Box of 1's)
OTC
Lloyd Laboratories Inc.Philippines
Kodapharm Med Corp.Trader: Vamsler Phils. Incorporated
DRP-4444-03
Jun 6, 2030
DeconsaphGuaifenesin + Phenylpropanolamine HCl + Chlorphenamine maleate
100 mg/15 mg/2 mg per 5 mL SyrupPET Round Amber Bottle with White HDPE Cap x 60 mL and 120 mL (Box of 1's)
Rx
Enicar Pharmaceuticals Pvt. Ltd.India
Importer: Nelpa Lifesciences, Inc.Trader: SAPPHIRE LIFESCIENCES PVT. LTD
DRP-9435
Dec 19, 2030
Deconsaph-PlusGuaifenesin + Phenylpropanolamine HCl + Chlorphenamine maleate
Syrup 100 mg/6.5 mg/2 mg per 5 mLPET Round Amber Bottle with White HDPE Cap x 60 mL and 120 mL (Box of 1's)
Rx
Enicar Pharmaceuticals Pvt. Ltd.India
Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd
DRP-9434
Dec 29, 2030
DefleminGuaifenesin + Chlorpheniramine Maleate + Phenylpropanolamine HydrochlorideVariant spelling
100 mg/2 mg/6.5 mg per 5 mL SyrupAmber glass bottle x 60 mL and 120 mL
Rx
San Marino Laboratories CorporationPhilippines
TGP Pharma Inc.Trader: Pharmacare Products Corporation
DRP-5149
Feb 7, 2027
Eleobron GPCGuaifenesin + Phenylpropanolamine hydrochloride + Chlorphenamine maleate
50 mg/6.25 mg/1 mg per 5 mL SyrupAmber Bottle x 60 mL; Amber Bottle x 120 mL
OTC
Lloyd Laboratories, Inc.Philippines
Trader: Vamsler Phils. Incorporated
DRP-4444
Jun 6, 2030
GeedexinGuiafenesin + Chlorpheniramine Maleate + Phenylpropanolamine HydrochlorideVariant spelling
100 mg/2 mg/6.5 mg per 5 mL SyrupAmber Glass Bottle x 60 mL and 120 mL (Box of 1's)
Rx
San Marino Laboratories CorporationPhilippines
Medilyn DrugTrader: Pharmacare Products Corporation
DRP-5149-01
Feb 7, 2027
Medbron GPCGuaifenesin + Phenylpropanolamine hydrochloride + Chlorphenamine maleate
50 mg/6.25 mg/1 mg per 5 mL SyrupAmber Bottle x 60 mL and 120 mL
OTC
Lloyd Laboratories, Inc.Philippines
Ultramed Pharma, Inc.Trader: Vamsler Phils. Incorporated
DRP-4444-01
Mar 2, 2031
Media ExpectorantChlorphenamine Maleate + Phenylpropanolamine Hydrochloride + Guaifenesin
2 mg/5 mg/100 mg per 5 mL Syrup (Cherry Flavor)Boston Round Amber Glass Bottle x 60 mL and 120 mL (Box of 1's)
OTC
Azarias Pharmaceutical Laboratories Inc.Philippines
—
DRP-4142
Dec 13, 2027
MucugenChlorphenamine Maleate + Phenylpropanolamine Hydrochloride + Guaifenesin
2 mg/5 mg/100 mg per 5 mL SyrupBoston Round Amber Glass Bottle x 60 mL (Box of 1's)
OTC
Azarias Pharmaceutical Laboratories, Inc.Philippines
Eba Generisch Trading Inc.
DRP-4159-01
Dec 18, 2027
MuculerChlorphenamine Maleate + Phenylpropanolamine Hydrochloride + Guaifenesin
2 mg/5 mg/100 mg per 5 mL SyrupBoston Round Amber Glass Bottle x 60 mL and 120 mL (Box of 1's)
OTC
Azarias Pharmaceutical Laboratories Inc.Philippines
—
DRP-4159
Dec 18, 2027
MucunxtGuaifenesin + Phenylpropanolamine Hydrochloride + Chlorphenamine Maleate
100 mg/ 6.5 mg/ 2 mg per 5mL SyrupBoston round amber glass bottle x 60 mL and 120mL (Box of 1's)
OTC
Azarias Pharmaceutical Laboratories Inc.,Philippines
Trader: St. Raphael Archangel Pharmaceutical Product Distribution
DRP-14227
Jul 31, 2028
Neo-BromexanGuaifenesin + Phenylpropanolamine HCl + Chlorphenamine Maleate
100 mg/5 mg/2 mg per 5 mL SyrupBoston Round Amber Glass Bottle x 60 mL (Box of 1's)
OTC
MEDI-RX, INC.Philippines
—
DR-XY17119
Mar 24, 2029
PLURADECGuaifenesin + Phenylpropanolamine Hydrochloride + Chlorphenamine Maleate
100mg / 6.5mg / 2mg per 5mL SyrupAmber Bottle x 60mL and 120mL (Box of 1's)
OTC
San Marino Laboratories CorporationPhilippines
Regimed Pharmaceutical DistributorTrader: Johntann Internationale Pharmaceutical Corp.
DR-XY45392
May 20, 2029
PluragenGuaifenesin + Phenylpropanolamine HC1 Chlorphenamine MaleateVariant spelling
100 mg 6.5 mg/2 mg per 45 mL Syrup (Cherry Flavor)Boston Round Amber Bottle x 60 mL & 120 mL (Box of 1's)
OTC
Azarias Pharmaceutical LaboratoriesPhilippines
Trader: Eba Generisch Trading Inc.
DRP-16407
Mar 4, 2030
PlurexGuaifenesin Phenylpropanolamine Hydrochloride + Chlorphenamine Maleate
100mg/ 6.5mg/ 2mg per 5mL SyrupBoston Round Amber Glass Bottle x 60 mL & 120 mL (Box of 1's)
OTC
Azarias Pharmaceutical Laboratories Inc.Philippines
—
DRP-13822
Apr 27, 2028
PulmoxGuaifenesin + Phenylpropanolamine HCl + Chlorphenamine Maleate
100 mg / 6.5 mg / 2 mg SyrupBoston Round Glass Amber Bottle x 60 mL and 120 mL
OTC
San Marino Laboratories CorporationPhilippines
—
DRP-8639
Mar 12, 2031
SaphclophenesinGuaifenesin + Phenylpropanolamine HCl + Chlorphenamine MalaeateVariant spelling
50 mg/6.25 mg/1 mg per 5 mL Syrup (Mentholated Orange Flavor)PET Round Amber Bottle Sealed with White ROPP Alu Cap x 60 mL and 120 mL (Box of 1's)
OTC
Azine Healthcare Pvt. Ltd.India
Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd.
DRP-10232
Aug 13, 2036
SaphextorantGuaifenesin + Phenylpropanolamine HCl + Chlorphenamine maleate
100 mg/5 mg/2 mg per 5 mL SyrupPET Round Amber Bottle with White HDPE Cap x 60 mL and 120 mL (Box of 1's)
Rx
Azine Healthcare Pvt. Ltd.India
Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd
DRP-9377
Dec 15, 2030
SAPHEXTORANT-PLUSGuaifenesin + Phenylpropanolamine HCl + Chlorphenamine maleate
100 mg/6.5 mg/2 mg per 5 mL SyrupPET Round Amber Bottle with White HDPE Cap x 60 mL and 120 mL (Box of 1's)
Rx
Azine Healthcare Pvt. Ltd.India
Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd
DRP-9376
Jan 7, 2031

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .